- Home
- GME vs AXSM Comparison
GME vs AXSM Comparison
Compare GME & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GME | AXSM |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronics Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 9.0B |
| IPO Year | 2005 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GME | AXSM |
|---|---|---|
| Price | $22.10 | $156.33 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 17 |
| Target Price | $13.50 | ★ $210.65 |
| AVG Volume (30 Days) | ★ 4.6M | 481.9K |
| Earning Date | 03-24-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 133.33 | 38.56 |
| EPS | ★ 0.77 | N/A |
| Revenue | ★ $3,629,900,000.00 | N/A |
| Revenue This Year | $9.86 | $58.18 |
| Revenue Next Year | $2.83 | $55.45 |
| P/E Ratio | $29.24 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.94 | $86.99 |
| 52 Week High | $35.81 | $191.50 |
Technical Indicators
Market Signals| Indicator | GME | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 36.45 | 40.92 |
| Support Level | $21.10 | $150.75 |
| Resistance Level | $24.56 | $169.11 |
| Average True Range (ATR) | 0.69 | 4.57 |
| MACD | -0.18 | 0.69 |
| Stochastic Oscillator | 4.92 | 28.11 |
Price Performance
Historical ComparisonAbout GME GameStop Corporation
GameStop Corp is a U.S. multichannel video game, consumer electronics, and services retailer. The company operates across Europe, Canada, Australia, and the United States. The company sells new and second-hand video game hardware, physical and digital video game software, and video game accessories, mainly through GameStop, EB Games, and Micromania stores and international e-commerce sites. The majority of sales are from the United States. The company categorizes its products in three categories: Hardware and accessories, Software, and Collectibles. The company generates the majority of its revenue from the sale of Hardware and accessories products.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.